AJANTPHARMBSEAjanta Pharma Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Tue, 9 Jun, 2026 · 10:21 IST

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 08, 2026 for Gabs Investments Pvt Ltd

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.3%Reaction day
₹2970.00
prior close
₹3026.40
announcement price
In-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+1.3%-0.0% vs market
Pharmaceuticals peers, median of 163sector+1.5%-0.2% vs sector

On the reaction day the stock moved in line with Nifty Midcap 150 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.1
15m
-0.1
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.3+1.3-0.0+1.5-0.2
Next day
+3.6-0.0+3.6+0.4+3.2
2d
+5.8-0.9+6.7+0.2+5.6
3d
+6.1+1.5+4.5+1.1+5.0
4d
+2.6+3.0-0.4+1.3+1.3
5d
+4.0+3.4+0.6+1.5+2.6
1w
+3.9+4.4-0.6+2.0+1.9
15d
+12.6+4.1+8.5+5.4+7.3
1m
+11.3+4.2+7.0+5.8+5.4
2m
+18.1+7.0+11.1+6.6+11.6
3m
+18.3+4.9+13.4+9.5+8.8
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 163Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter Gabs Investments Pvt Ltd has created a pledge on 27,70,000 shares of Ajanta Pharma Ltd, which is about 2.22% of the company's total share capital. The pledge was created on June 2, 2026, in favor of CTL Trusteeship Limited, and the stated reason is to raise a new loan. Gabs Investments holds 1,80,78,147 shares (14.47% of share capital) in the company, and before this event it had no shares pledged, so this is a fresh pledge. The disclosure was filed on June 3, 2026, under SEBI's SAST Regulations by Aayush Agrawal, Director of Gabs Investments. The total promoter group continues to hold a substantial stake, with multiple family members and trusts appearing in the promoter table.

Likely market impact

This is a small pledge creation covering only 2.22% of total share capital, so the immediate impact on the stock is limited. However, retail investors should watch for any further pledges or any sign of margin calls, as large or repeated pledging can sometimes signal financial stress at the promoter level.